“The Pharma or Biotech Deal Communicated”
Appeared November 5, 2003 in Pharmalicensing

Article Synopsis:
In the absence of profitability, unlike most other for-profit entities, a biotech company relies on news flow as one of the most important measurements of progress. Signing a collaborative agreement is an example of a newsworthy event that can demonstrate how a company is speeding along the product or service development timeline towards profitability. The forms and types of collaboration agreements are quite varied but in essence they all have one thing in common – they substantiate how a company is delivering on its strategic objectives. Whether licensing a product to a large pharmaceutical company, or sharing the development costs with a peer biotech, such agreements are signed every day. They are also communicated daily but with different levels of success.

If you are a client or prospective clients, please click here to contact us. A complete copy of the article you selected will be sent to you via e-mail .